The Hydration Pharmaceuticals Company Ltd
The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australi… Read more
The Hydration Pharmaceuticals Company Ltd (HPC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.606x
Based on the latest financial reports, The Hydration Pharmaceuticals Company Ltd (HPC) has a cash flow conversion efficiency ratio of -0.606x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.64 Million) by net assets (AU$2.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
The Hydration Pharmaceuticals Company Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how The Hydration Pharmaceuticals Company Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
The Hydration Pharmaceuticals Company Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of The Hydration Pharmaceuticals Company Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BAAPL
PINK:BAAPL
|
N/A |
|
Kaixin Auto Holdings
NASDAQ:KXIN
|
-0.133x |
|
Spuntech
TA:SPNTC
|
0.036x |
|
ProConcept Marketing Group Inc.
PINK:LNTO
|
0.098x |
|
Environmental Waste International Inc
PINK:YEWTF
|
0.130x |
|
BANCA GENERALI
BE:B7A
|
N/A |
|
Viracta Therapeutics Inc
NASDAQ:VIRX
|
1.072x |
|
Xigem Technologies Corporation
PINK:XIGMF
|
0.627x |
Annual Cash Flow Conversion Efficiency for The Hydration Pharmaceuticals Company Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$2.74 Million | AU$-3.02 Million | -1.101x | -106.89% |
| 2023-12-31 | AU$-358.25K | AU$-5.73 Million | 15.993x | +752.93% |
| 2022-12-31 | AU$3.98 Million | AU$-9.75 Million | -2.449x | -301.06% |
| 2021-12-31 | AU$13.23 Million | AU$-8.08 Million | -0.611x | +68.33% |
| 2020-12-31 | AU$2.00 Million | AU$-3.86 Million | -1.928x | -69.48% |
| 2019-12-31 | AU$2.44 Million | AU$-2.78 Million | -1.138x | +43.84% |
| 2018-12-31 | AU$2.66 Million | AU$-5.40 Million | -2.026x | -- |